Anti-fibroblast activation protein antibodies
AssigneePhilogen S.P.A.
InventorsRoberto DE LUCA, Lisa NADAL, Frederik PEISSERT
Life of this patent
Estimating the term…
Abstract
The application relates to the diagnosis and treatment of diseases, including cancer, autoimmune diseases and inflammatory disorders. The invention provides, and involves the use of, antibody molecules that bind fibroblast activation protein (FAP) from humans, sheep, pigs and domestic dogs. The antibody molecules may be conjugated to a pro-inflammatory agent, an anti-inflammatory agent, a biocidal molecule, a cytotoxic molecule, or a radioisotope.
Claims22
An antibody molecule that binds human, canine, ovine and porcine fibroblast activation protein (FAP), wherein the antibody molecule comprises a VH domain comprising a set of complementarity determining regions HCDR1, HCDR2 and HCDR3, and a VL domain comprising a set of complementarity determining regions LCDR1, LCDR2 and LCDR3, wherein:
- the HCDR1, HCDR2 and HCDR3 comprise the amino acid sequences set forth in SEQ ID NOs 3, 4 and 5, respectively, and
- the LCDR1, LCDR2 and LCDR3 comprise the amino acid sequences set forth in SEQ ID NOs 6, 7 and 8, respectively.
(canceled)
(canceled)
Dependencies are inferred from the claim text.